VEC.L Share News (VEC)

16 Nov 2010

Positive phase II data for its Parkinson's disease treatment has pushed up shares in Vectura. The VR040 treatment shows positive outcomes on the ab...

22 Oct 2010

Print heads developer Xaar continues to rise after yesterday's positive trading statement and fundraising. The shares are trading at a 32% premium t...

21 Oct 2010

Argos Resources and Rockhopper Exploration have both signed contracts for a seismic survey of their prospect in the Falklands Basin with Polarcus, the...

6 Aug 2010

GlaxoSmithKline has signed a worldwide non-exclusive deal with Vectura worth £20m in up front and milestone payments. GSK wants to use some of Vectu...

6 Aug 2010

Vectura is at its highest since mid- March after GlaxoSmithKline agreed a £20m deal to license some of the inhaled therapies developer's formulation p...

2 Aug 2010

1321 GMT [Dow Jones] Ambrian initiates coverage of Vectura Group (VEC.LN) with a buy rating and fair value of 98p. Analyst Chris Redhead says the drug...

2 Aug 2010

Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markett...

14 Jun 2010

John Hutson, the chief executive of pub operator JD Wetherspoon, has sold nearly one-third of his shareholding in the company. Hutson sold 30,000 sh...